Choice Pain & Rehabilitation Center, LLC
Choice Pain & Rehabilitation Center, LLC was paid $3.69M by Medicaid between Dec 2021 and Dec 2024, across 3 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 73% of everything it billed.
BALTIMORE, MD 21224
Next to other Pain Medicine (Physical Medicine & Rehabilitation) Physician providers in Maryland
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 456 | $55K | |
| 2022 | 5,767 | $556K | |
| 2023 | 18,266 | $1.59M | |
| 2024incomplete | 17,426 | $1.50M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 73% | 21,945 | 20,597 | $2.71M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 27% | 19,939 | 18,675 | $979K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 31 | 30 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Choice Pain & Rehabilitation Center, LLC | Lanham, MD | $11.10M |
| Choice Pain & Rehabilitation Center | Lanham, MD | $2.61M |
| Choice Pain & Rebabilitation Center LLC | Columbia, MD | $146K |
| Choice Pain & Rehabilitation Center, LLC | Rosedale, MD | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.